TDI’s case study is an example of IARC’s failure to consider a chemical’s primary route of exposure
Bob Masterson, President and CEO of The Chemistry Industry Association of Canada
The IARC Monographs Program has been plagued by transparency issues and conflicts of interest
The IARC and the flawed carcinogenic classifications of its tarnished Monographs Program are influencing policy again
The House Science, Space and Technology Committee held a full committee hearing on Feb. 6
the number of agents the International Agency for Research (IARC) on Cancer has now researched before finding one substance that was “probably not” likely to cause cancer in humans.